WATSON 835 3.75 (Clorazepate 3.75 mg)

Pill imprint WATSON 835 3.75 has been identified as Clorazepate dipotassium 3.75 mg.

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for WATSON 835 3.75

Clorazepate dipotassium 3.75 mg WATSON 835 3.75 Front
Clorazepate dipotassium 3.75 mg WATSON 835 3.75 Back
Clorazepate dipotassium 3.75 mg WATSON 835 3.75
Clorazepate dipotassium
Imprint:
WATSON
835 3.75
Strength:
3.75 mg
Color:
Blue
Shape:
Five-sided
Availability:
Prescription only
Drug Class:
Benzodiazepines
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Laboratories, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)